Donor Cancer Transmission: Focusing on the Evidence
- PMID: 35417114
- DOI: 10.1097/TP.0000000000004118
Donor Cancer Transmission: Focusing on the Evidence
Conflict of interest statement
The author declares no funding or conflicts of interest.
Comment on
-
Malignancies in Deceased Organ Donors: The Spanish Experience.Transplantation. 2022 Sep 1;106(9):1814-1823. doi: 10.1097/TP.0000000000004117. Epub 2022 Apr 1. Transplantation. 2022. PMID: 35421045 Review.
References
-
- Penn I. Transplantation of kidneys containing primary malignant tumors. Transplantation. 1973;16:674–675.
-
- Risk of transmission of neoplastic diseases. In: European Committee (Partial Agreement) on Organ Transplantation. Guide to the Quality and Safety of Organs for Transplantation. 7th ed. European Directorate for the Quality of Medicines & Healthcare of the Council of Europe; 2018:219–264.
-
- Mahillo B, Martin S, Molano E, et al. Malignancies in deceased organ donors: the Spanish experience. Transplantation. 2022;106:1814–1823.
-
- Warrens AN, Birch R, Collett D, et al.; Advisory Committee on the Safety of Blood, Tissues and Organs, UK. Advising potential recipients on the use of organs from donors with primary central nervous system tumors. Transplantation. 2012;93:348–353.
-
- Dholakia S, Johns R, Muirhead L, et al. Renal donors with prostate cancer, no longer a reason to decline. Transplant Rev (Orlando). 2016;30:48–50.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
